| Levobupivacaine 1.25 mg/mL solution for infusion PA2059/009/002 |
Levobupivacaine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Levobupivacaine 2.5 mg/mL solution for injection/infusion PA2059/009/003 |
Levobupivacaine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Levobupivacaine 5.0 mg/mL solution for injection/infusion PA2059/009/004 |
Levobupivacaine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Levobupivacaine 7.5 mg/mL solution for injection/infusion PA2059/009/005 |
Levobupivacaine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Levodopa/Carbidopa/Entacapone Orion 100 mg/25 mg/200 mg film-coated tablets EU/1/11/706/012-017 |
Levodopa, Entacapone, Carbidopa monohydrate |
Orion Corporation |
— |
| Levodopa/Carbidopa/Entacapone Orion 125 mg/31.25 mg/200 mg film-coated tablets EU/1/11/706/018-022 |
Levodopa, Entacapone, Carbidopa monohydrate |
Orion Corporation |
— |
| Levodopa/Carbidopa/Entacapone Orion 150 mg/37.5 mg/200 mg film-coated tablets EU/1/11/706/023-028 |
Levodopa, Carbidopa monohydrate, Entacapone |
Orion Corporation |
— |
| Levodopa/Carbidopa/Entacapone Orion 175 mg/43.75 mg/200 mg film-coated tablets EU/1/11/706/034-38 |
Entacapone, Carbidopa monohydrate, Levodopa |
Orion Corporation |
— |
| Levodopa/Carbidopa/Entacapone Orion 200 mg/50 mg/200 mg film-coated tablets EU/1/11/706/029-033 |
Entacapone, Levodopa, Carbidopa monohydrate |
Orion Corporation |
— |
| Levodopa/Carbidopa/Entacapone Orion 75 mg/18.75 mg/200 mg film-coated tablets EU/1/11/706/007-011 |
Levodopa, Carbidopa monohydrate, Entacapone |
Orion Corporation |
— |
| Levofloxacin 5 mg/ml solution for infusion, freeflex bags PA2059/010/002 |
Levofloxacin |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Levofloxacin 5 mg/ml solution for infusion, LDPE bottles PA2059/010/001 |
Levofloxacin |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Libmeldy 2-10 x 106 cells/mL dispersion for infusion EU/1/20/1493/001 |
Autologous CD34+ cell enriched population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the Human Arylsulfatase a Gene |
Orchard Therapeutics (Netherlands) B.V. |
— |
| Libmyris EU/1/21/1590/001-006 |
Adalimumab |
Stada Arzneimittel AG |
— |
| Libmyris 80 mg solution for injection in pre-filled syringe EU/1/21/1590/007 |
Adalimumab |
Stada Arzneimittel AG |
— |
| LIBTAYO 350 mg Concentrate for solution for infusion EU/1/19/1376/001 |
CEMIPLIMAB |
Regeneron Ireland U.C. |
— |
| Lidocaine Hydrochloride 1% w/v Solution for Injection PA2059/003/001 |
Lidocaine Hydrochloride Monohydrate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Lidocaine Hydrochloride 2% w/v Solution for Injection PA2059/003/002 |
Lidocaine Hydrochloride Monohydrate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Lifmior EU/1/16/1165/001 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/002-004 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/005-007 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/008-010 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Lifmior EU/1/16/1165/011-013 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Linagliptin MSN 5 mg film-coated tablets PA23250/022/001 |
Linagliptin |
MSN Labs Europe Limited |
Not marketed |
| Linezolid 2 mg/ml solution for infusion PA2059/011/001 |
Linezolid |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Lipocomb 10 mg/10 mg hard capsules PA1470/004/001 |
Ezetimibe, Rosuvastatin zinc tetrahydrate |
EGIS Pharmaceuticals PLC |
Not marketed |
| Lipocomb 20 mg/10 mg hard capsules PA1470/004/002 |
Ezetimibe, Rosuvastatin zinc tetrahydrate |
EGIS Pharmaceuticals PLC |
Not marketed |
| Lipocomb 40 mg/10 mg hard capsules PA1470/004/003 |
Ezetimibe, Rosuvastatin zinc tetrahydrate |
EGIS Pharmaceuticals PLC |
Marketed |
| Liprolog EU/1/01/195/028-029 |
|
Eli Lilly and Company Limited |
— |
| Liprolog EU/1/01/195/22-27 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Liprolog 100 units/ml, solution for injection in vial EU/1/01/195/001 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Liprolog 100 units/ml, solution for injection in vial EU/1/01/195/002 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Liprolog Mix25 EU/1/01/195/003 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Liprolog Mix25 Pen EU/1/01/195/006 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Liprolog Mix50 EU/1/01/195/004 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Liprolog Mix50 Pen EU/1/01/195/007 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Liprolog-Pen EU/1/01/195/005 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| Litak 2 mg/ml solution for injection EU/1/04/275/001-002 |
Cladribine |
Lipomed GmbH |
— |
| Litfulo 50 mg hard capsules EU/1/23/1755/001-003 |
Ritlecitinib |
Pfizer Europe MA EEIG |
— |
| Livazo 1mg film-coated tablets PA2324/001/001 |
Pitavastatin |
Kowa Pharmaceutical Europe GmbH |
Not marketed |
| Livazo 2mg film-coated tablets PA2324/001/002 |
Pitavastatin |
Kowa Pharmaceutical Europe GmbH |
Not marketed |
| Livazo 4mg film-coated tablets PA2324/001/003 |
Pitavastatin |
Kowa Pharmaceutical Europe GmbH |
Not marketed |
| Livmarli 9.5 mg/mL oral solution EU/1/22/1704/001 |
Maralixibat Chloride |
Mirum Pharmaceuticals International B.V. |
— |
| Livogiva 20 micrograms/80 microliters solution for injection in pre-filled pen EU/1/20/1462/001-002 |
Teriparatide |
Theramex Ireland Limited |
— |
| LIVTENCITY 200 mg film-coated tablets EU/1/22/1672/001-002 |
Maribavir |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Lixiana 15 mg film-coated tablets EU/1/15/993/001 |
Edoxaban tosilate |
Daiichi Sankyo Europe GmbH |
— |
| Lixiana 30 mg film-coated tablets EU/1/15/993/002 |
Edoxaban tosilate |
Daiichi Sankyo Europe GmbH |
— |
| Lixiana 60 mg film-coated tablets EU/1/15/993/003 |
Edoxaban tosilate |
Daiichi Sankyo Europe GmbH |
— |
| Loargys 5 mg/ml solution for injection/infusion EU/1/23/1774/001-002 |
Pegzilarginase |
Immedica Pharma AB |
— |
| Locametz 25 micrograms kit for radiopharmaceutical preparation EU/1/22/1692/001 |
Gozetotide |
Advanced Accelerator Applications |
— |